Croda, Inc.


Manufacturer of specialty ingredients and technologies for consumer care, life sciences (including pharmaceutical excipients and vaccine adjuvants), crop care and industrial applications. Operates global manufacturing and R&D sites, provides formulation and delivery-platform capabilities, and maintains sustainability and life-cycle assessment programmes.

Industries

N/A


Products

Specialty ingredient portfolios

High-value ingredients intended to deliver targeted functional performance at low inclusion rates across personal care, homecare, fragrance, crop protection and pharmaceutical formulations.

Encapsulation and delivery systems

Delivery systems for controlled release and enhanced stability or performance of active ingredients in consumer and industrial applications, including biodegradable options.


Services

Formulation and technical support services

Laboratory and customer-facing formulation development, performance testing and technical assistance across consumer care, personal care, homecare, flavours and fragrances.

Pharmaceutical materials and delivery platform services

Supply and development of pharmaceutical-grade excipients, adjuvant systems and delivery materials to support vaccine and biologics formulation and scale-up.

Sustainability and LCA support

Life cycle assessment, sustainability reporting and datapacks to quantify environmental impacts and support customer disclosure and product strategy.

Expertise Areas

  • Specialty ingredient manufacturing and scale-up
  • Formulation development for consumer and industrial markets
  • Pharmaceutical excipients and vaccine adjuvant development
  • Delivery and encapsulation technologies
  • Show More (5)

Key Technologies

  • Encapsulation and controlled-release systems
  • Lipid excipient synthesis
  • Vaccine adjuvant formulation
  • Biosurfactant production
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.